Neuronetics, Inc. Increase (Decrease) in Accounts Payable
Neuronetics, Inc. (STIM) reported Increase (Decrease) in Accounts Payable of $1.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-11
- Neuronetics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $1.01M, a 21.32% increase year-over-year.
- Neuronetics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $559.00K.
- Neuronetics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.67M.
- Neuronetics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.73M.
- Neuronetics, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$1.75M.
- Neuronetics, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$1.99M, a 197.83% decline from fiscal 2023.
- Neuronetics, Inc. increase (decrease) in accounts payable for fiscal 2023 was $2.03M.
- Neuronetics, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$1.97M, a 813.04% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.57M 10-Q · filed 2026-08-11 | -$101.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.63M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $559.00K 10-Q · filed 2026-05-05 | -$1.11M derived: sum of 2 quarters · filed 2026-05-05 | $612.00K derived: sum of 3 quarters · filed 2026-05-05 | $1.45M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $53.00K derived: sum of 2 quarters · filed 2026-03-17 | $888.00K derived: sum of 3 quarters · filed 2026-08-11 | -$1.75M 10-K · filed 2026-03-17 |
| 2025-09-30 | $1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.56M derived: sum of 2 quarters · filed 2026-08-11 | -$77.00K 10-Q · filed 2025-11-04 | -$538.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $835.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$1.80M 10-Q · filed 2026-08-11 | -$2.26M derived: sum of 3 quarters · filed 2026-08-11 | -$2.94M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$2.64M 10-Q · filed 2026-05-05 | -$3.10M derived: sum of 2 quarters · filed 2026-05-05 | -$3.78M derived: sum of 3 quarters · filed 2026-05-05 | -$2.64M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$461.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$1.14M derived: sum of 2 quarters · filed 2026-03-17 | -$2.00K derived: sum of 3 quarters · filed 2026-03-17 | -$1.99M 10-K · filed 2026-03-17 |
| 2024-09-30 | -$680.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $459.00K derived: sum of 2 quarters · filed 2025-11-04 | -$1.52M 10-Q · filed 2025-11-04 | $451.00K derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$844.00K 10-Q · filed 2025-08-05 | $1.13M derived: sum of 3 quarters · filed 2026-03-17 | -$392.00K derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-03-31 | -$1.98M 10-Q · filed 2025-05-06 | -$8.00K derived: sum of 2 quarters · filed 2026-03-17 | -$1.53M derived: sum of 3 quarters · filed 2026-03-17 | -$2.44M derived: sum of 4 quarters · filed 2026-03-17 |
| 2023-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $452.00K derived: sum of 2 quarters · filed 2026-03-17 | -$455.00K derived: sum of 3 quarters · filed 2026-03-17 | $2.03M 10-K · filed 2026-03-17 |
| 2023-09-30 | -$1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$2.43M derived: sum of 2 quarters · filed 2024-11-12 | $54.00K 10-Q · filed 2024-11-12 | $285.00K derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-06-30 | -$907.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $1.58M 10-Q · filed 2024-08-12 | $1.81M derived: sum of 3 quarters · filed 2025-03-27 | $1.86M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-03-31 | $2.48M 10-Q · filed 2024-05-07 | $2.71M derived: sum of 2 quarters · filed 2025-03-27 | $2.77M derived: sum of 3 quarters · filed 2025-03-27 | $2.74M derived: sum of 4 quarters · filed 2025-03-27 |
| 2022-12-31 | $231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $288.00K derived: sum of 2 quarters · filed 2025-03-27 | $258.00K derived: sum of 3 quarters · filed 2025-03-27 | -$1.97M 10-K · filed 2025-03-27 |
| 2022-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $27.00K derived: sum of 2 quarters · filed 2023-11-07 | -$2.20M 10-Q · filed 2023-11-07 | -$1.08M derived: sum of 4 quarters · filed 2024-03-08 |
| 2022-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$2.26M 10-Q · filed 2023-08-08 | -$1.14M derived: sum of 3 quarters · filed 2024-03-08 | -$615.00K derived: sum of 4 quarters · filed 2024-03-08 |
| 2022-03-31 | -$2.23M 10-Q · filed 2023-05-15 | -$1.11M derived: sum of 2 quarters · filed 2024-03-08 | -$585.00K derived: sum of 3 quarters · filed 2024-03-08 | -$1.26M derived: sum of 4 quarters · filed 2024-03-08 |
| 2021-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $1.64M derived: sum of 2 quarters · filed 2024-03-08 | $970.00K derived: sum of 3 quarters · filed 2024-03-08 | $276.00K 10-K · filed 2024-03-08 |
| 2021-09-30 | $525.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$146.00K derived: sum of 2 quarters · filed 2022-11-08 | -$840.00K 10-Q · filed 2022-11-08 | $415.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | -$671.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$1.36M 10-Q · filed 2022-08-02 | -$110.00K derived: sum of 3 quarters · filed 2023-03-07 | -$42.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | -$694.00K 10-Q · filed 2022-05-12 | $561.00K derived: sum of 2 quarters · filed 2023-03-07 | $629.00K derived: sum of 3 quarters · filed 2023-03-07 | -$480.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $1.32M derived: sum of 2 quarters · filed 2023-03-07 | $214.00K derived: sum of 3 quarters · filed 2023-03-07 | -$1.08M 10-K · filed 2023-03-07 |
| 2020-09-30 | $68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$1.04M derived: sum of 2 quarters · filed 2021-11-09 | -$2.34M 10-Q · filed 2021-11-09 | -$2.05M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | -$1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$2.41M 10-Q · filed 2021-08-03 | -$2.12M derived: sum of 3 quarters · filed 2022-03-08 | -$1.88M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | -$1.30M 10-Q · filed 2021-05-04 | -$1.01M derived: sum of 2 quarters · filed 2022-03-08 | -$772.00K derived: sum of 3 quarters · filed 2022-03-08 | $475.00K derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $527.00K derived: sum of 2 quarters · filed 2022-03-08 | $1.77M derived: sum of 3 quarters · filed 2022-03-08 | $299.00K 10-K · filed 2022-03-08 |
| 2019-09-30 | $238.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $1.49M derived: sum of 2 quarters · filed 2020-11-02 | $10.00K 10-Q · filed 2020-11-02 | $1.21M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$228.00K 10-Q · filed 2020-08-04 | $972.00K derived: sum of 3 quarters · filed 2021-03-02 | $467.00K derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-31 | -$1.48M 10-Q · filed 2020-05-05 | -$275.00K derived: sum of 2 quarters · filed 2021-03-02 | -$780.00K derived: sum of 3 quarters · filed 2021-03-02 | -$1.13M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $695.00K derived: sum of 2 quarters · filed 2021-03-02 | $343.00K derived: sum of 3 quarters · filed 2021-03-02 | $606.00K 10-K · filed 2021-03-02 |
| 2018-09-30 | -$505.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$857.00K derived: sum of 2 quarters · filed 2019-11-05 | -$594.00K 10-Q · filed 2019-11-05 | $1.01M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | -$352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$89.00K 10-Q · filed 2019-08-06 | $1.52M derived: sum of 3 quarters · filed 2020-03-03 | $1.97M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | $263.00K 10-Q · filed 2019-05-07 | $1.87M derived: sum of 2 quarters · filed 2020-03-03 | $2.32M derived: sum of 3 quarters · filed 2020-03-03 | |
| 2017-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $2.06M derived: sum of 2 quarters · filed 2020-03-03 | $788.00K 10-K · filed 2020-03-03 | |
| 2017-09-30 | $451.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$819.00K 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | -$1.27M 10-Q · filed 2018-08-14 | |||
| 2016-12-31 | $734.00K 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |